Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-cadherin: target for cancer diagnosis and therapy

N-cadherin: target for cancer diagnosis and therapy

US Patent 9470689 · Granted Oct 18, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targe2016
Antibodies against cancer target block tumor growth, angiogenesis and metastatis2016
High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targe2015
Engineered anti-prostate stem cell antigen (PSCA) antibodies for cancer targetin2015
PSCA: prostate stem cell antigen and distinguishing androgen receptor negative p2014
Fully human antibodies against N-cadherin2014
N-cadherin: target for cancer diagnosis and therapy2014
PSCA: prostate stem cell antigen and uses thereof2013
Humanized anti-prostate stem cell antigen monoclonal antibody2013
Humanized anti-prostate stem cell antigen monoclonal antibody2012
Mouse models of human prostate cancer2009
Methods for inhibiting the growth of cancer cells expressing PSCA2009